查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654642

全球電穿孔儀器市場 - 2025 至 2033 年

Global Electroporation Instruments Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球電穿孔儀器市場規模達到 2.5142 億美元，預計到 2033 年將達到 3.7404 億美元，2025-2033 年預測期內的複合年成長率為 4.5%。

電穿孔儀器是用於促進電穿孔的設備，電穿孔是一種向細胞施加短電脈衝以暫時增加其膜通透性的技術。這使得 DNA、RNA、蛋白質或藥物等物質能夠被引入細胞，而這個過程對於生物技術、基因工程和醫學中的各種應用至關重要。電穿孔廣泛應用於基因研究、藥物傳遞、疫苗接種和蛋白質生產，因為與傳統方法相比，它允許分子物質更有效、更直接地轉移到細胞中。這些儀器因其精確度、有效性以及處理多種細胞類型（包括真核細胞和原核細胞）的能力而受到高度重視。

受生物技術進步、研究活動的增加以及基因編輯和治療應用需求不斷成長的推動，電穿孔儀器市場正在經歷顯著成長。例如，2024年6月，博騰生物將MaxCyte cGMP級ExPERT GTx流式電穿孔儀引入其細胞治療平台，標誌著該公司成為中國第一家擁有該臨床級流式電穿孔系統的細胞治療CDMO。

市場動態：

促進因素與約束因素

科技進步日新月異

不斷進步的技術極大地推動了電穿孔儀器市場的成長，並預計在預測期內推動市場的發展。電穿孔已成為癌症治療的關鍵技術，尤其是透過電化學療法。該方法包括向腫瘤施加電脈衝，增加細胞膜通透性並允許化療藥物更有效地進入癌細胞。技術進步提高了該技術的精確度和安全性，為皮膚和皮下腫瘤患者帶來了更好的治療效果。

例如，2024 年 10 月，AngioDynamics 與倫敦大學學院醫院 (UCLH) 合作啟動了一項前瞻性註冊研究，評估奈米刀系統治療單灶中危前列腺癌的長期效果。此奈米刀系統使用不可逆電穿孔技術來治療腫瘤，透過傳遞高壓電脈衝在細胞膜上產生微小孔隙，從而導致可控細胞死亡，而不會損害周圍組織。

CRISPR-Cas9等基因編輯技術的發展增加了對電穿孔儀器的需求。電穿孔有助於將基因編輯成分有效地遞送到細胞中，從而推動研究和治療應用。這導致電穿孔儀器在基因工程和治療干預中的應用激增。

電穿孔儀器成本高

電穿孔儀器的高成本限制了其可及性和採用率，嚴重阻礙了市場的成長，尤其是對於預算有限的小型實驗室和研究機構。例如，新型電穿孔系統的成本通常在 3,000 美元到 20,000 美元之間，具體取決於型號、特性和能力。

電穿孔儀器的價格昂貴，只有資金充足的實驗室和研究中心才能購買，而較小的機構則無法投資此類技術。這種差異導致無法平等地獲得先進的研究工具，阻礙了市場的整體成長。高昂的設備成本可能導致研究項目和新療法開發的延遲，因為機構可能缺乏採購和維護這些儀器所需的資源。研究活動的放緩可能會阻礙該領域的科學進步和創新。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 不斷進步的技術
    • 限制
      • 電穿孔儀器成本高
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • 新興創業公司和關鍵創新者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：電穿孔儀器市場（依產品類型）

  • 儀器
    • 全電穿孔系統
    • 真核電穿孔系統
    • 微生物電穿孔系統
  • 配件
    • 電穿孔比色皿
    • 電極
    • 錢伯斯
    • 套件
    • 其他

第 6 章：電穿孔儀器市場（依應用）

  • 蛋白質生產
  • 藥物輸送
  • 生物醫學研究

第 7 章：電穿孔儀器市場（依最終用戶分類）

  • 醫院
  • 實驗室
  • 生技及製藥公司
  • 研究與學術機構
  • 其他

第 8 章：電穿孔儀器市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第9章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第10章：公司簡介

  • Bio-Rad Laboratories, Inc.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • MaxCyte
  • Lonza Group
  • BEX CO., LTD.
  • Celetrix, LLC.
  • Harvard Bioscience, Inc.
  • Bulldog Bio, Inc.
  • Spectrocell Inc.

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MD3818

The global electroporation instruments market reached US$ 251.42 million in 2024 and is expected to reach US$ 374.04 million by 2033, growing at a CAGR of 4.5% during the forecast period 2025-2033.

Electroporation instruments are devices used to facilitate electroporation, a technique that involves applying short electrical pulses to cells to temporarily increase the permeability of their membranes. This allows for the introduction of substances like DNA, RNA, proteins, or drugs into the cell, a process that is essential for various applications in biotechnology, genetic engineering, and medicine. Electroporation is widely used in genetic research, drug delivery, vaccination, and protein production, as it allows for more efficient and direct transfer of molecular substances into cells compared to traditional methods. The instruments are highly valued for their precision, effectiveness, and ability to handle a variety of cell types, including both eukaryotic and prokaryotic cells.

The electroporation instruments market is experiencing significant growth, driven by advancements in biotechnology, increased research activities, and the rising demand for gene editing and therapeutic applications. For instance, in June 2024, Porton Advanced introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to possess this clinical-grade flow electroporation system.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements are significantly driving the growth of the electroporation instruments market and are expected to drive the market over the forecast period. Electroporation has become a pivotal technique in cancer treatment, particularly through electrochemotherapy. This method involves applying electrical pulses to tumors, increasing cell membrane permeability and allowing chemotherapeutic agents to enter cancer cells more effectively. Technological advancements have improved the precision and safety of this technique, leading to better treatment outcomes for patients with cutaneous and subcutaneous tumors.

For instance, in October 2024, AngioDynamics with the University College London Hospital (UCLH) launched a prospective registry study evaluating the long-term effects of the NanoKnife system for treating unifocal intermediate-risk prostate cancer. This NanoKnife system uses irreversible electroporation technology to treat tumors by delivering high-voltage electrical pulses that create tiny pores in cell membranes, leading to controlled cell death without harming surrounding tissues.

The development of gene editing technologies, such as CRISPR-Cas9, has increased the demand for electroporation instruments. Electroporation facilitates the efficient delivery of gene-editing components into cells, thereby advancing research and therapeutic applications. This has led to a surge in the adoption of electroporation instruments in genetic engineering and therapeutic interventions.

The high cost of the electroporation instruments

The high cost of electroporation instruments significantly hampers the growth of the market by limiting accessibility and adoption, particularly among smaller laboratories and research institutions with constrained budgets. For instance, the cost of the new electroporation systems typically ranges from $3,000 to $20,000, depending on the model, features and capabilities.

The substantial expense of electroporation instruments restricts their acquisition to well-funded laboratories and research centers, leaving smaller institutions unable to invest in such technologies. This disparity results in unequal access to advanced research tools, hindering the overall growth of the market. High equipment costs can lead to delays in research projects and the development of new therapies, as institutions may lack the necessary resources to procure and maintain these instruments. This slowdown in research activities can impede scientific progress and innovation within the field.

Segment Analysis

The global electroporation instruments market is segmented based on product type, application, end-user and region.

Product Type:

The instruments segment is expected to dominate the electroporation instruments market share

In the electroporation instruments market, the instruments segment including total electroporation systems, eukaryotic electroporation systems and microbial electroporation systems holds a dominant position over the accessories segment. This dominance is primarily due to the essential role that electroporation systems play in the process, as they generate the electrical pulses necessary for cell membrane permeabilization.

These electroporation instruments are the core devices for researchers to transfect even the most difficult cell types with excellent efficiency, cell recovery, and repeatability and these instruments apply electrical pulses to cells, facilitating the introduction of substances like DNA, RNA, or drugs. The market for these systems is substantial, with projections indicating significant growth.

For instance, in April 2023, Thermo Fisher Scientific launched the Invitrogen Neon NxT Electroporation System, which allows researchers to transfect even the most difficult cell types with excellent efficiency, cell recovery, and repeatability. Neon NxT electrodes are ideally positioned and have a small surface area to provide a more uniform electric field and keep physiological parameters stable during transfection. These advantages allow the intended alteration to occur in more cells, with fewer cells lost during the transfection process. The new system also has an enhanced feedback loop and ergonomic advancements for ease of usage.

Geographical Analysis

North America is expected to hold a significant position in the electroporation instruments market share

North America especially the United States boosts a well-established healthcare system with state-of-the-art research laboratories, facilitating the adoption and integration of advanced technologies like electroporation instruments. The presence of major market players in the region particularly in the United States fosters innovations and advancements in electroporation instruments.

For instance, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages a closed, highly flexible design to facilitate gene modifications without the use of traditional viral vectors. The electroporation approach enables the introduction of a payload into a cell by temporarily increasing cell permeability using an electrical pulse.

Asia-Pacific is growing at the fastest pace in the electroporation instruments market

The region is witnessing significant progress in biotechnology and molecular biology research. Electroporation instruments are essential for gene editing, protein production, and other biomedical applications. The expansion of research facilities and increased funding are contributing to the adoption of these technologies.

For instance, China has been leading investments in biotechnology with initiatives such as "Made in China 2025," which focuses on integrating advanced technologies into manufacturing and healthcare sectors. This initiative is expected to bolster the demand for electroporation instruments as part of broader biotechnological advancements.

As emerging economies in Asia-Pacific continue to develop their biotech sectors, there is an increasing demand for electroporation instruments for applications in biomedical research and therapeutic delivery56. Countries like India are investing heavily in science and technology, which further supports market growth

Competitive Landscape

The major global players in the electroporation instruments market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, MaxCyte, Lonza Group, BEX CO., LTD., Celetrix, LLC., Harvard Bioscience, Inc., Bulldog Bio, Inc., Spectrocell Inc. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electroporation instruments market report delivers a detailed analysis with 62 key tables, more than 53 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Electroporation Instruments
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Electroporation Instruments Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Instruments*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Total Electroporation Systems
    • 5.2.4. Eukaryotic Electroporation Systems
    • 5.2.5. Microbial Electroporation Systems
  • 5.3. Accessories
    • 5.3.1. Electroporation Cuvettes
    • 5.3.2. Electrodes
    • 5.3.3. Chambers
    • 5.3.4. Kits
    • 5.3.5. Others

6. Electroporation Instruments Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Protein Production*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Drug Delivery
  • 6.4. Biomedical Research

7. Electroporation Instruments Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Laboratories
  • 7.4. Biotechnology and Pharmaceutical Companies
  • 7.5. Research and Academic Institutions
  • 7.6. Others

8. Electroporation Instruments Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Bio-Rad Laboratories, Inc.*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. Thermo Fisher Scientific Inc.
  • 10.3. Merck KGaA
  • 10.4. MaxCyte
  • 10.5. Lonza Group
  • 10.6. BEX CO., LTD.
  • 10.7. Celetrix, LLC.
  • 10.8. Harvard Bioscience, Inc.
  • 10.9. Bulldog Bio, Inc.
  • 10.10. Spectrocell Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us